4-94334521-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014485.3(HPGDS):c.109G>A(p.Ala37Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00002 in 1,446,456 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014485.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HPGDS | NM_014485.3 | c.109G>A | p.Ala37Thr | missense_variant | 2/6 | ENST00000295256.10 | |
HPGDS | XM_005262932.4 | c.109G>A | p.Ala37Thr | missense_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HPGDS | ENST00000295256.10 | c.109G>A | p.Ala37Thr | missense_variant | 2/6 | 1 | NM_014485.3 | P1 | |
ENST00000667612.1 | n.2871-8423C>T | intron_variant, non_coding_transcript_variant | |||||||
HPGDS | ENST00000506331.1 | n.200G>A | non_coding_transcript_exon_variant | 2/2 | 3 | ||||
HPGDS | ENST00000514774.1 | n.189G>A | non_coding_transcript_exon_variant | 2/5 | 4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000834 AC: 2AN: 239732Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 129490
GnomAD4 exome AF: 0.0000200 AC: 29AN: 1446456Hom.: 0 Cov.: 31 AF XY: 0.0000167 AC XY: 12AN XY: 719008
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2021 | The c.109G>A (p.A37T) alteration is located in exon 2 (coding exon 1) of the HPGDS gene. This alteration results from a G to A substitution at nucleotide position 109, causing the alanine (A) at amino acid position 37 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at